These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4020622)

  • 21. Prediction of human percutaneous absorption from in vitro and in vivo animal experiments.
    Yoshimatsu H; Ishii K; Konno Y; Satsukawa M; Yamashita S
    Int J Pharm; 2017 Dec; 534(1-2):348-355. PubMed ID: 29111099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of numerical methods for diffusion-based modeling of skin permeation.
    Frasch HF; Barbero AM
    Adv Drug Deliv Rev; 2013 Feb; 65(2):208-20. PubMed ID: 22261307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.
    Wester RC; Maibach HI
    Drug Metab Rev; 1983; 14(2):169-205. PubMed ID: 6341024
    [No Abstract]   [Full Text] [Related]  

  • 24. Percutaneous absorption: a single-layer model.
    Kubota K; Sznitowska M; Maibach HI
    J Pharm Sci; 1993 May; 82(5):450-6. PubMed ID: 8360820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal drug delivery in vitro using diffusion cells.
    Bartosova L; Bajgar J
    Curr Med Chem; 2012; 19(27):4671-7. PubMed ID: 22934776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The application of feature selection to the development of Gaussian process models for percutaneous absorption.
    Lam LT; Sun Y; Davey N; Adams R; Prapopoulou M; Brown MB; Moss GP
    J Pharm Pharmacol; 2010 Jun; 62(6):738-49. PubMed ID: 20636861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of bioavailability: measurement of absorption through skin in vitro.
    Hotchkiss SA
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit 5.1.1-14. PubMed ID: 20949434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A calculation of percutaneous drug absorption--II. Computation results.
    Kubota K; Ishizaki T
    Comput Biol Med; 1986; 16(1):21-37. PubMed ID: 3948493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of thermodynamic activity and vapour diffusion through human skin for the model compound, benzyl alcohol.
    Barry BW; Harrison SM; Dugard PH
    J Pharm Pharmacol; 1985 Feb; 37(2):84-90. PubMed ID: 2858555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fully computational model for predicting percutaneous drug absorption.
    Neumann D; Kohlbacher O; Merkwirth C; Lengauer T
    J Chem Inf Model; 2006; 46(1):424-9. PubMed ID: 16426076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interfacial kinetics effects on transdermal drug delivery: a computer modeling.
    Xing MM; Pan N; Zhong W; Hui X; Maibach HI
    Skin Res Technol; 2008 May; 14(2):165-72. PubMed ID: 18412558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of cutaneous drug penetration.
    Franz TJ
    Int J Dermatol; 1983 Nov; 22(9):499-505. PubMed ID: 6358066
    [No Abstract]   [Full Text] [Related]  

  • 36. Distributed diffusion-clearance model for transient drug distribution within the skin.
    Kretsos K; Kasting GB; Nitsche JM
    J Pharm Sci; 2004 Nov; 93(11):2820-35. PubMed ID: 15389667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling drug flux through microporated skin.
    Rzhevskiy AS; Guy RH; Anissimov YG
    J Control Release; 2016 Nov; 241():194-199. PubMed ID: 27686580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for in vitro percutaneous absorption studies. VII: Use of excised human skin.
    Bronaugh RL; Stewart RF; Simon M
    J Pharm Sci; 1986 Nov; 75(11):1094-7. PubMed ID: 3820104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacokinetic model for the percutaneous absorption of indomethacin and the prediction of drug disposition kinetics.
    Ogiso T; Ito Y; Iwaki M; Atago H
    J Pharm Sci; 1989 Apr; 78(4):319-23. PubMed ID: 2724095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug absorption in aging].
    Bezverkhaia IS; Zapadniuk VI
    Farmakol Toksikol; 1985; 48(1):109-12. PubMed ID: 3884363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.